RecruitingPhase 3NCT07560306
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Studying Amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brigham and Women's Hospital
- Intervention
- [64Cu]FBP8 PET/MR(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Brigham and Women's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07560306 on ClinicalTrials.govOther trials for Amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07494656A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in GermanyPfizer
- RECRUITINGPHASE2NCT07285044The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo Clinic
- RECRUITINGNCT07218705A Study Of MCG In Cardiac AmyloidosisMayo Clinic
- ENROLLING BY INVITATIONPHASE2NCT06723015Tau PET Outcomes With Anti-amyloid ImmunotherapiesMayo Clinic
- RECRUITINGNCT07213297Comprehensive Program for Hereditary Transthyretin AmyloidosisHospital de Alta Complejidad en Red
- RECRUITINGPHASE1NCT06790394Test-retest Study With [18F]FBB in Cardiac AmyloidosisLife Molecular Imaging GmbH
- RECRUITINGNANCT07112066Multimodality Cardiac Imaging for Disease Progression in ATTR-CMDominik Benz
- RECRUITINGPHASE3NCT07207811CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisNovo Nordisk A/S